Maria Carmen Valcarce Lopez

This inventor holds 16 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Diabetes Treatment. Top assignees: Vtv Therapeutics LLC, Novo Nordisk A/s. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Carmen Valcarce Lopez. Retrieved from https://idiyas.com/inventor/maria-carmen-valcarce-lopez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 9)

% Patents Active = 93.8

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 96(Granted Patents)

Company Filing History:

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

Glucokinase Activators

Insulin

Diabetes

PPAR-Delta Agonist

Muscle Atrophy

Metformin

Muscle Strength

Alzheimer's Disease

Compositions

Therapeutic Uses

Muscle Mass

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11974989 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2024-05-07),

2. 11833136 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2023-12-05),

3. 11096946 - Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb (2021-08-24),

4. 10980861 - Glucokinase activator compositions for the treatment of diabetes (2021-04-20),

5. 10952993 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2021-03-23),

6. 10588943 - Glucokinase activator compositions for the treatment of diabetes (2020-03-17),

7. 10456406 - Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb (2019-10-29),

8. 10363244 - Compositions comprising metformin and a glucokinase activator (2019-07-30),

9. 10064846 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-09-04),

10. 10004782 - Glucokinase activator compositions for the treatment of diabetes (2018-06-26),

11. 9968613 - Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb (2018-05-15),

12. 9855251 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-01-02),

13. 9717710 - Treatment of mild and moderate Alzheimer's disease (2017-08-01),

14. 9487493 - Use of a PPAR-delta agonist for treating muscle atrophy (2016-11-08),

15. 9359313 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2016-06-07),

Certainly! Here is the article about inventor Maria Carmen Valcarce Lopez:

Title: Maria Carmen Valcarce Lopez: Innovating for a Healthier Future

Introduction: Maria Carmen Valcarce Lopez is a prolific inventor based in Oak Ridge, NC, with a remarkable portfolio of 15 patents. She is dedicated to advancing healthcare through cutting-edge inventions that have the potential to transform the treatment of various medical conditions.

Latest Patents: Maria's latest patents showcase her expertise in the medical field. One notable invention is the therapeutic uses of glucokinase activators in combination with insulin or insulin analogs. This innovation offers new methods for treating type 1 diabetes by administering a glucokinase activator alongside insulin. Another patent focuses on using a PPAR-𝛿 agonist to reduce muscle loss in immobilized limbs.

Career Highlights: Maria has made significant contributions to the field while working with companies like VTV Therapeutics LLC and Novo Nordisk A/S. Her innovative spirit and dedication to improving healthcare have earned her recognition among peers and industry experts.

Collaborations: Throughout her career, Maria has collaborated with esteemed professionals in the field, including Adnan M. M. Mjalli and Eliot Ohlstein. These collaborations have brought forth groundbreaking inventions that have the potential to impact the lives of many individuals.

Conclusion: Maria Carmen Valcarce Lopez's passion for innovation and dedication to improving healthcare have led to the development of impactful patents in the medical field. Her collaborative efforts and inventive solutions stand as a testament to her commitment to creating a healthier future for all.

Profile summary based on public USPTO records.